Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

Palantir Shares Navigate Market Turbulence

Dieter Jaworski by Dieter Jaworski
November 16, 2025
in AI & Quantum Computing, Market Commentary, Tech & Software
0
Palantir Stock
0
SHARES
119
VIEWS
Share on FacebookShare on Twitter

While much of the technology sector faced selling pressure last Wednesday, Palantir managed a notable reversal, climbing from negative territory into the green. This impressive performance, however, masks underlying tensions. CEO Alex Karp has introduced a note of uncertainty with unusually critical commentary, warning that numerous artificial intelligence investments might ultimately prove worthless. Is the AI bubble showing signs of deflation, even for one of its primary beneficiaries?

Strong Fundamentals Meet Market Skepticism

The company’s fundamental performance appears robust. In early November, Palantir released spectacular figures for its third quarter of 2025:

  • Revenue: $1.18 billion (a 63% year-over-year increase)
  • Earnings Per Share: $0.21 (significantly surpassing analyst forecasts)
  • Raised Annual Guidance: Total revenue projected between $4.396 billion and $4.400 billion

A particular standout was the performance of its US commercial business, which exploded with 121 percent growth. Despite these strong results, the stock reached its 52-week high of $207.52 on November 3rd and has since undergone a notable correction. The core issue appears to be a valuation that many consider ambitious, even for a growth stock. This has led to increasing skepticism, with many analysts maintaining “Hold” ratings.

CEO Sounds a Note of Caution on AI Hype

Alex Karp, known for his pointed public appearances, adopted an unusually critical tone in mid-November. In public statements, he cautioned that a significant number of investments in the AI sector may fail to justify their substantial costs. He emphasized that only measurable outcomes—such as expanded profit margins and tangible revenue growth—would ultimately matter. His core message was clear: artificial intelligence must evolve beyond mere hype and deliver concrete, demonstrable value.

Should investors sell immediately? Or is it worth buying Palantir?

For Palantir, a company whose entire business model is built on data-driven AI software, this stance presents a paradox. On one hand, Karp positions himself as a critical voice in an overheated market. On the other, his comments inevitably fuel doubts about whether his own company’s market valuation is justified, despite its impressive quarterly earnings.

Conflicting Signals and the Path Forward

The recent trading activity highlights a clear market dilemma: powerful fundamental data is colliding with nervous investors questioning whether the current share price can be sustained. Karp’s own critique of the AI sector provides additional fodder for doubters and, simultaneously, ammunition for the short sellers he has publicly denounced.

All eyes are now on the fourth-quarter results. The critical questions are whether Palantir can meet its own revenue forecast of over $1.3 billion, announce new major contracts, and thereby provide concrete proof that its AI software generates genuine, measurable value. The alternative is a potential consolidation of the current market sentiment—that even solid business performance may not be enough to support its present valuation.

Ad

Palantir Stock: Buy or Sell?! New Palantir Analysis from February 7 delivers the answer:

The latest Palantir figures speak for themselves: Urgent action needed for Palantir investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Palantir: Buy or sell? Read more here...

Tags: Palantir
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Yirendai Stock
AI & Quantum Computing

Yirendai Charts a New Course with Tech-Driven Strategy

February 7, 2026
ServiceNow Stock
AI & Quantum Computing

ServiceNow Shares Face Market Skepticism Despite Record Performance

February 7, 2026
OneSpan Stock
Cyber Security

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026
Next Post
Voestalpine Stock

Voestalpine Shares Surge on Historic Contract Win

DeFi Technologies Stock

DeFi Technologies Shares Plunge on Revenue Warning and Leadership Shake-Up

PayPal Stock

PayPal Shares Face Pressure as Analyst Downgrade Offsets Expansion Efforts

Recommended

C3.ai Stock

Is C3.ai Stock Poised for a Rebound?

2 months ago
MMM stock news

Clarification on Hyperlink and Promotional Fees

2 years ago

XOMA Corporation Expands Portfolio with Acquisition of DSUVIA

2 years ago
Microsoft Stock

A Bold Bet: Peter Thiel’s Hedge Fund Doubles Down on Microsoft

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

ServiceNow Shares Face Market Skepticism Despite Record Performance

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

A New Chapter for First Busey as CrossFirst Merger Finalizes

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Trending

Avanos Medical Stock
Analysis

Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

by SiterGedge
February 7, 2026
0

Avanos Medical is navigating a critical strategic transformation. The medical device firm is streamlining its operations to...

Guaranty Bancshares Stock

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

February 7, 2026
Yirendai Stock

Yirendai Charts a New Course with Tech-Driven Strategy

February 7, 2026
ServiceNow Stock

ServiceNow Shares Face Market Skepticism Despite Record Performance

February 7, 2026
Orthofix Medical Stock

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth
  • Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion
  • Yirendai Charts a New Course with Tech-Driven Strategy

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com